Testosterone versus hCG in Hypogonadotropic Hypogonadism – Comparing Clinical Effects and Evaluating Current Practice

Background. Gonadotropin therapy is not typically used for pubertal induction in hypogonadotropic hypogonadism (HH), however, represents a promising alternative to testosterone. It can potentially lead to the maintenance of future fertility in addition to testicular growth. We compared the pubertal...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Swashti, Tu, Duong D., Austin, Paul F., Scheurer, Michael E., Karaviti, Lefkothea P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851198/
https://www.ncbi.nlm.nih.gov/pubmed/35187206
http://dx.doi.org/10.1177/2333794X20958980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851198/
https://www.ncbi.nlm.nih.gov/pubmed/35187206
http://dx.doi.org/10.1177/2333794X20958980

Ejemplares similares